Drug recall · November 8, 2017
Duloxetine Delayed-release Capsules USP recall
Why: Failed Impurities/Degradation Specifications: slightly elevated levels of phthalic acid.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Duloxetine Delayed-release Capsules USP, 20 mg, 50 Capsules (5 x 10) Unit Dose per carton, unit dose blister UPC 5026828311), Rx only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, NDC 50268-283-15.
- Lots / codes
Lot: 18103 Exp. 11/18
- Quantity
- 274 cartons
- Company
- AVKARE Inc., Pulaski, TN
- Distribution
- Nationwide in the USA
- Initiated
- October 6, 2017 · Voluntary: Firm initiated
- Classified
- October 27, 2017
- Reported
- November 8, 2017
- Ended
- March 11, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Duloxetine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.